Is this you?
Request access for New England Cancer Specialists with your @newenglandcancerspecialists.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
New England Cancer Specialists
Unclaimed profileIndependent Network · Scarborough, Maine (100 Campus Drive, Unit 108) · ~5 sites
Intera lens
ICP 6Lift (cardio sample) 0.05Recruit soph 0.57
Quality Scorecard (1–100)
Overall65Recruit54Ops78Sponsor60Ther68
Performance (observed)
Historical trials
137
Completed
70
Terminated/Withdrawn
9
Completion rate
89%
Active now
56
Phase 2
26
Phase 3
100
Realized enrollment
157,660
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
4,927
Therapeutic
Areas
Medical Oncology, Hematology, Radiation Oncology, Breast Surgery, Non-oncological Infusion
Breadth (conditions)
221
Languages
English
States
Maine, New Hampshire
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Strong recruitment messaging; media strategy includes digital
Capability notes
High - Active cancer trials, Dana-Farber affiliate partnership, multi-location network
Relationships
Sponsors
Hoffmann-La Roche; Pfizer; National Cancer Institute (NCI); Merck Sharp & Dohme LLC; Eli Lilly and Company; Genentech, Inc.
CROs
MacroGenics; Syneos Health
Partnerships
Dana-Farber Cancer Institute, National Cancer Care Alliance (100+ locations)
Owner / parent
Independent (Affiliate of Dana-Farber Cancer Institute)
Expansion
Serves Maine and New Hampshire; expanding access
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown (Board-led structure; Dr. Chiara Battelli was Board President through 2025)
VP Clinical Ops
Claire Cote (Chief Operations Officer)
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Research@newecs.org (provided from input)
Tech & DCT
CTMS
Deep Lens VIPER (trial matching platform)
eSource
Yes
Builds tech
Vendors
DCT / decentralized
Y (site mentions)
Tech stack
Precision medicine platforms, EDC systems
Recruiting visible
Y
Notes
ClinicalTrials.gov signal: 6 recruiting trials across 5 locations in Maine and New Hampshire. Leading independent oncology practice north of Boston. Dana-Farber affiliate partnership provides access to cutting-edge trials. ASCO Medical Home Certified. 50+ year track record. Strong regional oncology presence but limited to New England geography and oncology specialty.
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.05Overall65
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.